Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome-A retrospective observational study.
<h4>Background</h4>Nephrotic syndrome (NS) is associated with increased risk of venous thromboembolism (VTE). Guidelines suggest prophylactic anticoagulants to patients with high risk of thrombosis and low risk of bleeding, but the evidence behind this is poor. This study aims to investi...
Guardado en:
Autores principales: | Frida Welander, Henrik Holmberg, Emöke Dimény, Ulf Jansson, Anders Själander |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/56db623d1a9b4067bd43a63ec7d5d371 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study
por: Gualtiero Palareti MD, et al.
Publicado: (2021) -
Oral anticoagulants for the treatment of venous thromboembolism and non-valvular atrial fibrillation: a cost analysis
por: Isabella C DENARDIN, et al.
Publicado: (2021) -
Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
por: Masarret Fazili, et al.
Publicado: (2020) -
Prevention and treatment of venous thromboembolism in the elderly patient
por: Enrico Tincani, et al.
Publicado: (2007) -
Claims‐Based Score for the Prediction of Bleeding in a Contemporary Cohort of Patients Receiving Oral Anticoagulation for Venous Thromboembolism
por: Alvaro Alonso, et al.
Publicado: (2021)